HomeHIV/AIDS
HIV/AIDS
Novel intervention halves death rate in those with HIV who inject drugs
An intervention designed to facilitate treatment for HIV and substance use was associated with a 50% reduction in mortality for people living with HIV...
Patient navigation programmes linked to continuation of HIV care
Patient navigation programmes in HIV care are positively associated with HIV care continuum outcomes such as maintenance of antiretroviral therapy (ART) and retention in...
Appropriate pain management may have role in key HIV treatment outcomes
Chronic pain was reported by a quarter of people living with HIV in US study. Among people reporting ongoing pain of moderate intensity or...
Neuro-psychiatric side effects with dolutegravir
A large study by French researchers at CHU de Martinique, INSERM UMR 1027 - Toulouse, Nice University Hospital, Pitié Salpetrière University Hospital, Paris, Marseille...
One in nine people could control viral load after stopping treatment
A US collaboration that pooled data from 14 scientific studies containing between them more than 600 HIV-positive people has found that 67 of them...
Critical need for integrated health services in HIV-affected populations
Many young adults living with perinatally acquired HIV infection reach young adult milestones related to school, employment and sexual relationships, research shows. "We were...
Janssen announces positive results from ATLAS study
Janssen has announced positive top-line results from a Phase 3 trial for an investigational long-acting 2-drug regimen for HIV-1 infection.
According to an Infectious Disease...
Attitude a top attribute for preferred healthcare provider — Zambia study
As a healthcare patient, what would you sacrifice for a provider with a nice – rather than rude – attitude? Medical Xpress reports that...
Pressing need to address heavy drinking among MSM with HIV
Among the more than 1m people in the US living with HIV, 19% meet the criteria for an alcohol use disorder. The consequences can...
Dolutegravir monotherapy an unsafe switch option
Using dolutegravir alone, as maintenance treatment after achieving undetectable viral load on a three-drug regimen, results in an unacceptable rate of viral rebound and...
Patients receiving methadone and HIV drugs spend less time with detectable viral load
People on methadone maintenance treatment spent less time with a detectable viral load above 1,500 copies/ml, potentially reducing the risk of HIV transmission, a...
Surprise HIV finding in SA circumcision study
Circumcision is a proven intervention that reduces the chance of contracting HIV by 60%, but a study has found that medically circumcised older men...
Another 2-drug HIV antiretroviral regimen emerges
Not only is there a once-daily pill that can control HIV infection with just 2 drugs and fewer side effects than the customary 3-...
Dolutegravir brings faster viral suppression in late pregnancy
Among 60 women presenting to routine antenatal clinics in Kampala, Uganda and Cape Town, South Africa with undiagnosed HIV in late pregnancy, viral load...
No more neural tube defects reported in Botswana dolutegravir study
From 1 May to 15 July 2018 there were no more neural tube defects reported among infants born to women taking dolutegravir (DTG) at...
Reproductive health needs of women with HIV in SSA
The needs for safe conception services and a wider choice of contraception for women living with HIV in sub-Saharan Africa were highlighted recently at...
Treating adverse events resulting from vaccinations in HIV-positive individuals
Although HIV dysregulates the immune system, recent research does not indicate unexpected patterns of adverse events (AEs) resulting from vaccinations in HIV-positive individuals, according...
Similar virological suppression for those switching to once-daily darunavir/ritonavir
Stable patients on a twice-daily lopinavir/ritonavir (LPV/r)-based second-line regimen who switched to a once-daily 400/100 mg darunavir/ritonavir (DRV/r) one maintained similar virological suppression to...
Reduction of new HIV infections in SSA's youth is far off-track
Africa is far off-track in reducing new HIV infections among children and young people and is unlikely to reduce new infections in young people...
Clues to ways prevention programmes could be optimised
Substantial decreases in HIV diagnoses in key cities show the way to elimination of new HIV diagnoses in gay men, a workshop at the...
Pricing agreement lowers cost of diagnostic testing in emerging economies
A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/Aids, hepatitis and cervical cancer for millions of people in low-...
Kaposi's sarcoma remains a concern for people with HIV
A small proportion of people living with HIV continue to develop Kaposi's sarcoma (KS), a cancer linked to immune suppression, according to studies presented...
Encouraging results from Merck's doravirine trial
Doravirine, the experimental antiretroviral developed by Merck, suppressed HIV at a higher rate compared with Norvir (ritonavir)-boosted Prezista (darunavir) 96 weeks into a clinical...
'Dangerous complacency' risks resurgence of HIV pandemic — Lancet Commission
A ‘dangerous complacency’ in response to the global HIV pandemic is risking a resurgence of the disease, found theLancet Commission, led by the International...
The 'favoured child' still desperately needs intervention
Almost four decades on and despite having benefited as favoured child of global health funding, the HIV/Aids epidemic is far from over, writes Professor Linda-Gail...
Persistently high rate of HIV infections scares SA's health minister
The high rate of HIV infections in South Africa has left Health Minister Dr Aaron Motsoaledi “scared”. City Press reports that Motsoaledi was addressing...
Donor cuts could threaten global progress on HIV
If donor government funding for HIV continues to fall, nearly two decades of progress against the disease will be in jeopardy, according to new...
HIV data from sub-Saharan Africa gives reasons for hope
Researchers and public health experts presented promising new data on the HIV epidemic and response in sub-Saharan Africa at the 22nd International AIDS Conference...
Insufficient evidence for recommendations on breastfeeding for mothers with HIV
Research is urgently needed to provide clear recommendations on breastfeeding to mothers with HIV who have an undetectable viral load on antiretroviral treatment, a...
HIV-positive children more likely to have developmental disabilities
HIV-positive children in South Africa are more likely to have developmental disabilities compared to children who are HIV negative, according to researchers at Columbia...
MSM show preference for using HIV self-testing kits
A study that gave HIV self-testing kits out to 127 mainly young men who have sex with men (MSM) in two regions in north-east...
Reduced dose darunavir safe and effective in viral suppression
In well-suppressed, treatment-experienced adults with HIV, decreasing the dose of ritonavir-boosted darunavir (darunavir/r) from the standard dose is associated with a high rate of...
Dolutegravir in people who experienced virological failure with older integrase inhibitors
Antiretroviral regimens containing dolutegravir, a next-generation integrase inhibitor, are durable and achieve high rates of viral suppression in people who experienced virological failure with...
Novel online prevention programme cut STIs by 40%
A novel online HIV prevention programme with spicy soap operas and interactive games – like a rising thermometer of sexual risk – reduced sexually...
Most physicians willing to prescribe PrEP to teens
US regulators said in May that a pill that helps prevent infection with HIV is safe for use by adolescents, and a study suggests...
Important to inform children of their seropositive status
School-age children should be informed of their seropositive status and disclosure for younger children should occur incrementally, according to a research review.
In 2016, approximately...
Rilpivirine better tolerated, less toxic than efavirenz in first-line ART
Rilpivirine is better tolerated, less toxic and more durable than efavirenz when used as part of a first-line antiretroviral regimen, investigators from the Infectious...
HIV factors not associated with increased risk of suicide in France
Approximately 4% of deaths among people with HIV in France are due to suicide, investigators report. Suicide incidence remained stable over 13 years of...
New alert on using darunavir/cobicistat during pregnancy
Janssen Pharmaceuticals has issued a new alert against using darunavir/cobicistat during pregnancy. This new contraindication is based on significantly reduced plasma levels of...
Long periods of viral suppression reduces cancer risk in HIV population
Early, sustained antiretroviral therapy (ART), which results in long-term viral suppression, helps to prevent Aids-defining cancers and also non-Aids-defining cancers, to a lesser degree....